earnings
TL
NASDAQ · TLSI
TriSalus Life Sciences, Inc.
Healthcare · Medical - Devices
$4.93
Up+$0.06 (+1.12%)
Updated Sep 17, 2026, 3:14 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 247.45M
- P/E ratio
- -4.6
- Dividend yield
- 0.00%
- 52-week range
- $2.20 – $7.95
- Volume
- 156.51K
- Avg. volume
- 137.4K
Price performance
TLSI price history
1M range · 20 trading sessions · Daily adjusted prices
TLSI closed at $4.93 after 20 trading sessions, down 10.20% for the selected period.
- Last close
- $4.93
- Period change
- -10.20%
- Period low
- $4.67
- Period high
- $5.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $4.82 | $4.95 | $4.47 | $4.93 | 156.51K |
| Sep 15, 2026 | $4.76 | $4.79 | $4.53 | $4.78 | 162.5K |
| Sep 14, 2026 | $4.63 | $4.845 | $4.5823 | $4.77 | 101.31K |
| Sep 11, 2026 | $4.79 | $4.855 | $4.59 | $4.665 | 100.26K |
| Sep 10, 2026 | $4.71 | $4.80 | $4.65 | $4.70 | 68.47K |
| Sep 9, 2026 | $4.90 | $4.91 | $4.68 | $4.76 | 119.35K |
| Sep 8, 2026 | $4.94 | $4.99 | $4.48 | $4.73 | 129.3K |
| Sep 4, 2026 | $4.92 | $5.125 | $4.92 | $5.00 | 86.87K |
| Sep 3, 2026 | $5.24 | $5.37 | $4.92 | $4.98 | 70.24K |
| Sep 2, 2026 | $5.18 | $5.37 | $5.0155 | $5.14 | 250.64K |
| Sep 1, 2026 | $4.96 | $5.23 | $4.935 | $5.17 | 82.57K |
| Aug 31, 2026 | $4.85 | $5.025 | $4.81 | $4.95 | 72.69K |
| Aug 28, 2026 | $4.94 | $5.2399 | $4.7001 | $4.83 | 79.97K |
| Aug 27, 2026 | $4.90 | $5.11 | $4.72 | $4.93 | 74.62K |
| Aug 26, 2026 | $5.04 | $5.04 | $4.815 | $4.93 | 92.31K |
| Aug 25, 2026 | $5.10 | $5.26 | $4.965 | $5.03 | 174.8K |
| Aug 24, 2026 | $5.30 | $5.30 | $5.03 | $5.11 | 86.91K |
| Aug 21, 2026 | $5.21 | $5.35 | $5.18 | $5.27 | 98.69K |
| Aug 20, 2026 | $5.43 | $5.43 | $5.22 | $5.23 | 74.98K |
| Aug 19, 2026 | $5.47 | $5.57 | $5.36 | $5.49 | 178.25K |
Latest TLSI news
The latest Smart Investors Daily articles mentioning TLSI.
Stock researchMarket Activity · Insider Trades
Loading stock research…

